| GLECAPREVIR + PIBRENTASVIR |
Maviret® |
AbbVie Pty Ltd |
Chronic Hepatitis C infection |
Dec 2020 |
Recommended |
| ETANERCEPT |
Brenzys® |
Merck Sharp & Dome (Australia) Pty Ltd |
Severe active rheumatoid arthritis; Ankylosing spondylitis; Severe psoriatic arthritis;
Severe chronic plaque psoriasis |
Dec 2020 |
Not Recommended |
| SAPROPTERIN |
Kuvan® |
Biomarin Pharmaceutical Australia Pty Ltd |
Maternal phenylketonuria (MPKU) |
Dec 2020 |
Recommended |
| LAROTRECTINIB |
Vitrakvi® |
Bayer Australia Ltd |
Solid tumours harbouring neurotrophic receptor tyrosine kinase (NTRK) gene fusions |
Dec 2020 |
Not Recommended |
| ADALIMUMAB |
Hadlima® |
Merck Sharp & Dome (Australia) Pty Ltd |
Severe Crohn disease; complex refractory fistulising Crohn disease; moderate to severe
ulcerative colitis; severe active juvenile idiopathic arthritis; adult patients with
a history of jovenile idiopathic arthritis; severe psoriatic arthritis; ankylosing
spondylitis; severe chronic plaque psoriasis; severe active rheumatoid arthritis |
Dec 2020 |
Not Recommended |